What impact would an HIV/AIDS vaccine have on the HIV/AIDS epidemic in Kenya?
- 1 Kenya AIDS Vaccine Initiative, Department of Medical Microbiology, University of Nairobi, Nairobi, Kenya
- 2 Kenya AIDS Vaccine Initiative, Department of Medical Microbiology, University of Nairobi, Nairobi, Kenya
- 3 Kenya AIDS Vaccine Initiative, Department of Medical Microbiology, University of Nairobi, Nairobi, Kenya
- 4 Kenya AIDS Vaccine Initiative, Department of Medical Microbiology, University of Nairobi, Nairobi, Kenya
- 5 School of Mathematics, University of Nairobi, Nairobi, Kenya
- 6 Futures Institute Glastonbury, USA
Abstract
Objective : To estimate the potential impact of an HIV/AIDS Vaccine in Kenya. Design : The Kenyan HIV/AIDS epidemic was modeled using the most current data from national sources including epidemiology and behavioral surveillance. The model’s baseline projection was validated against adult HIV prevalence at antenatal clinics and general population surveys. The model was used to analyze the effects of scaling up current prevention programs and adding potential HIV vaccines with varying levels of effectiveness and coverage. Results: Even with full scale-up of currently available prevention, care and treatment programs, new infections will continue to burden Kenya. The introduction of a partially effective AIDS vaccine could significantly alter the trajectory of the epidemic. Conclusion: The game changing impact that an AIDS vaccine could have on the AIDS epidemic in Kenya under-scores the importance of sustaining political support and financial investment to accelerate HIV/AIDS vaccine research and development.
- KAIS (2007) C Kenya AIDS Indicator Survey report.
- National AIDS and STD Control Programme (2010) National HIV indicators for Kenya: 2009. NASCOP/NACC, Nairobi.
- IAVI (2005) Modeling the impact of AIDS vaccines. International AIDS Vaccine Initiative, New York.
- Stover, J., Bollinger, L., Hecht, R. and Williams, C. (2007) The impact of an AIDS vaccine in developing countries: A new model and initial results health affairs, 26, 1147-1158
- Fonseca, M.G.P., Forsythe, S., Menezes, A., et al. (2010) Modeling HIV vaccines in Brazil: Assessing the impact of a future HIV vaccine on reducing new infections, mortality and number of people receiving ARV. PLoS One, 5, e11736. doi:10.1371/journal.pone.0011736
- Stover, J., Johnson, P., Zaba, B., et al. (2008) The spectrum projection package: Improvements in estimating mortality, ART needs, PMTCT impact and uncertainty bounds. Sexually Transmitted Infections, 84, i24-i30. doi:10.1136/sti.2008.029868
- Akwara, P.A., Madise, N.J. and Hinde, A. (2003). Perception of risk of HIV/AIDS and sexual behaviour in Kenya. Journal of Biosocial Science, 35, 385-411 doi:10.1017/S0021932003003857
- Angala, P., Parkinson, A., Kilonzo, N., Natecho, A. and Taegtmeyer, M. (2006) Men who have sex with men (MSM) as presented in VCT data in Kenya. XVI International AIDS Conference, Toronto, 13-18 August 2006.
- Auvert, B., Taljaard, D., Lagarde, E., et al. (2005) Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 trial. PLoS Medicine, 2, e298. doi:10.1371/journal.pmed.0020298
- Bailey, R.C., Moses, S., Parker, C.B., et al. (2007) Male circumcision for HIV prevention in young men in Kisumu, Kenya: A randomized controlled trial. Lancet, 369, 643-656. doi:10.1016/S0140-6736(07)60312-2
- HIV prevention response and modes of transmission analysis Kenya (March, 2009)
- KDHS (2003) 2003 preliminary report. Kenya Demographic and Health Survey.
- Zaba, B., Pisani, E., Slaymaker, E. and Boerma, J.T. (2004) Age at first sex: Understanding recent trends in African demographic surveys. Sexually Transmitted Infections, 80, ii28-ii35. doi:10.1136/sti.2004.012674
- Ngugi, E.N., Plummer, F.A., Simonsen, J.N., et al. (1988) Prevention of transmission of HIV in African and the effectiveness of condom promotion and health education among prostitutes. Lancet, 2, 887-890. doi:10.1016/S0140-6736(88)92480-4